These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8620668)

  • 21. Population pharmacokinetics of zileution, a selective 5-lipoxygenase inhibitor, in patients with rheumatoid arthritis.
    Awni WM; Granneman GR; Locke CS; Brandwein SR; Dube LM
    Eur J Clin Pharmacol; 1995; 48(2):155-60. PubMed ID: 7589031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
    Wong SL; Drajesk J; Chang M; Lanni C; Witt G; Hansen R; Awni WM
    Clin Pharmacol Ther; 1998 Mar; 63(3):324-31. PubMed ID: 9542476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep.
    Abraham WM; Ahmed A; Cortes A; Sielczak MW; Hinz W; Bouska J; Lanni C; Bell RL
    Eur J Pharmacol; 1992 Jul; 217(2-3):119-26. PubMed ID: 1330588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM; Cavanaugh JH; Leese P; Kasier J; Cao G; Locke CS; Dube LM
    Eur J Clin Pharmacol; 1997; 52(1):49-54. PubMed ID: 9143867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
    Liu MC; Dubé LM; Lancaster J
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
    Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
    Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies.
    Marr K; Marsh K; Hernandez L; Cunningham FM; Lees P
    Res Vet Sci; 1998; 64(2):111-7. PubMed ID: 9625466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteers.
    Uematsu T; Kanamaru M; Kosuge K; Hara K; Uchiyama N; Takenaga N; Tanaka W; Friedman BS; Nakashima M
    Br J Clin Pharmacol; 1995 Jul; 40(1):59-66. PubMed ID: 8527269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
    Lu P; Schrag ML; Slaughter DE; Raab CE; Shou M; Rodrigues AD
    Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroids.
    Dekhuijzen PN; Bootsma GP; Wielders PL; van den Berg LR; Festen J; van Herwaarden CL
    Eur Respir J; 1997 Dec; 10(12):2749-53. PubMed ID: 9493655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-lipoxygenase inhibitory activity of zileuton.
    Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
    J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
    Israel E; Cohn J; Dubé L; Drazen JM
    JAMA; 1996 Mar; 275(12):931-6. PubMed ID: 8598621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton.
    Coffey MJ; Phare SM; Peters-Golden M
    J Pharmacol Exp Ther; 2001 Oct; 299(1):198-203. PubMed ID: 11561080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
    DuBuske LM; Grossman J; Dubé LM; Swanson LJ; Lancaster JF
    Am J Manag Care; 1997 Apr; 3(4):633-40. PubMed ID: 10169531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
    Tu XK; Yang WZ; Shi SS; Chen CM; Wang CH
    Neurol Res; 2009 Oct; 31(8):848-52. PubMed ID: 19309543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.
    Wong SL; Drajesk J; Chang MS; Witt G; Awni WM
    Biopharm Drug Dispos; 1998 Apr; 19(3):159-62. PubMed ID: 9569998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
    Berger W; De Chandt MT; Cairns CB
    Int J Clin Pract; 2007 Apr; 61(4):663-76. PubMed ID: 17394438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Helfgott S; Maier AL; Petrillo G; Henson B; Rubin P; Sperling R
    J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.